Xiao Qin, Qian Yiwei, Liu Jiujiang, Xu Shaoqing, Yang Xiaodong
Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine, No. 197, Ruijin Er Road, Shanghai, 200025 China.
Transl Neurodegener. 2017 Apr 26;6:11. doi: 10.1186/s40035-017-0081-9. eCollection 2017.
Recent studies have found that the functional catechol-O-methyltransferase (COMT) gene may be associated with the susceptibility to and pharmacotherapy of Parkinson's disease (PD). In this case-control study, we investigated the most common functional COMT gene haplotypes that had been shown to influence COMT enzymatic activity and the association of the single and combined COMT haplotypes with clinical symptoms and pharmacotherapy in Chinese patients with PD.
One hundred forty-three patients with idiopathic PD and 157 healthy individuals were enrolled in this study. Four single nucleotide polymorphisms (SNPs) in the COMT gene (formed by SNPs) were genotyped in each participant: rs6269 A > G; rs4633 C > T; rs4818 C > G; and rs4680 G > A.
The frequencies of rs4633 T carriers, rs4680 A carriers and the two linked rs4633-rs4680 T/A carriers were significantly higher in the early onset PD group than in the healthy controls (all < 0.05). Homozygosity for rs4633 (TT), rs4680 (AA) and of the two linked rs4633-rs4680 (TT/AA) was significantly more frequent in patients who exhibited the "wearing-off" phenomenon, longer disease duration, higher levodopa equivalent doses (LED) and higher Unified Parkinson's Disease Rating Scale (UPDRS) scores ( < 0.05). No significant differences were observed in the clinical features of patients who carried individual rs6269 and rs4818, the two linked rs6269-rs4818 and the four combined COMT SNPs.
The results showed a possible association of combined functional COMT SNPs with PD risk, disease duration, the "wearing-off" phenomenon, daily LEDs and higher UPDRS scores, which may be useful in instituting individualized therapy for patients with PD.
近期研究发现,功能性儿茶酚-O-甲基转移酶(COMT)基因可能与帕金森病(PD)的易感性及药物治疗相关。在这项病例对照研究中,我们调查了已被证明会影响COMT酶活性的最常见功能性COMT基因单倍型,以及中国PD患者中单一和联合COMT单倍型与临床症状及药物治疗的关联。
本研究纳入了143例特发性PD患者和157名健康个体。对每位参与者的COMT基因中的四个单核苷酸多态性(SNP,由这些SNP构成)进行基因分型:rs6269 A>G;rs4633 C>T;rs4818 C>G;以及rs4680 G>A。
早发型PD组中rs4633 T携带者、rs4680 A携带者以及两个连锁的rs4633 - rs4680 T/A携带者的频率显著高于健康对照组(均P<0.05)。在出现“剂末现象”、病程较长、左旋多巴等效剂量(LED)较高以及统一帕金森病评定量表(UPDRS)评分较高的患者中,rs4633(TT)、rs4680(AA)以及两个连锁的rs4633 - rs4680(TT/AA)的纯合子频率显著更高(P<0.05)。携带单个rs6269和rs4818、两个连锁的rs6269 - rs4818以及四个联合的COMT SNP的患者的临床特征未观察到显著差异。
结果显示功能性COMT SNP联合可能与PD风险、病程、“剂末现象”、每日LED以及较高的UPDRS评分相关,这可能有助于为PD患者制定个体化治疗方案。